Efficacy of Fluoxetine Against Seizure-induced Central Apneas
NCT02569970
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Epilepsy
Ictal/Post-ictal Hypoxemia
Interventions
DRUG:
fluoxetine 20 mg
DRUG:
placebo 20 mg
Sponsor
Hospices Civils de Lyon